Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C

European Journal of Immunology

Volumn 43, Issue 7, 2013, Pages 1953-1962

  Zhang, Ji Yuan ^a   Wu, Xiao Li ^b   Yang, Bin ^a   Wang, Yu ^a   Feng, Guo Hua ^a   Jiang, Tian Jun ^a   Zeng, Qing Lei ^a   Xu, Xiang Sheng ^a   Li, Yuan Yuan ^a   Jin, Lei ^a   Lv, Sa ^a   Zhang, Zheng ^a   Fu, Junliang ^a   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Chronic hepatitis C (HCV); Monocyte; OX40 ligand

Indexed keywords

OX40 LIGAND; PEGINTERFERON ALPHA; RIBAVIRIN; TOLL LIKE RECEPTOR 2;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS LOAD;

CHRONIC HEPATITIS C (HCV); MONOCYTE; OX40 LIGAND;

ADULT; BIOLOGICAL MARKERS; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MONOCYTES; OX40 LIGAND; UP-REGULATION; YOUNG ADULT;

EID: 84880007305     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243097     Document Type: Article

References (30)

1. Ghany, M. G., Strader, D. B., Thomas, D. L. and Seeff, L. B., Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009. 49: 1335-1374.
2. Ghany, M. G., Nelson, D. R., Strader, D. B., Thomas, D. L. and Seeff, L. B., An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011. 54: 1433-1444.
3. Hepatotogy Branch, Infectious and Parasitology branch, Chinese Medical Association., Guideline of prevention and treatment of hepatitis C. Zhonghua Yu Fang Yi Xue Za Zhi 2004. 38: 210-215.
4. Rehermann, B. and Nascimbeni, M., Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005. 5: 215-229.
5. Rehermann, B., Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 2009. 119: 1745-1754.
6. Godfrey, W. R., Fagnoni, F. F., Harara, M. A., Buck, D. and Engleman, E., Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J. Exp. Med. 1994. 180: 757-762.
7. Calderhead, D. M., Buhlmann, J. E., van den Eertwegh, A. J., Claassen, E., Noelle, R J. and Fell, H. P., Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 1993. 151: 5261-5271.
8. Croft, M., Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 2010. 28: 57-78.
9. Karulf, M., Kelly, A., Weinberg, A. D. and Gold, J. A., OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis. J. Immunol. 2010. 185: 4856-4862.
10. Chen, A. I., McAdam, A. J., Buhlmann, J. E., Scott, S., Lupher, M. J., Greenfield, E. A., Baum, P. R. et al., OX40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999. 11: 689-698.
11. Redmond, W. L., Gough, M. J. and Weinberg, A. D., Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo. Eur. J. Immunol. 2009. 39: 2184-2194.
12. Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C. and Delespesse, G., Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 1997. 159: 3838-3848.
13. Murata, K., Ishii, N., Takano, H., Miura, S., Ndhlovu, L. C., Nose, M., Noda, T. et al., Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 2000. 191: 365-374.
14. Kopf, M., Ruedl, C., Schmitz, N., Gallimore, A., Lefrang, K., Ecabert, B., Odermatt, B. et al., OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity 1999. 11: 699-708.
15. Yu, Q., Yue, F. Y., Gu, X. X., Schwartz, H., Kovacs, C. M. and Ostrowski, M. A., OX40 ligation of CD4 +T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition. J. Immunol. 2006. 176: 2486-2495.
16. Ahmed, R., Butler, L. D. and Bhatti, L., T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 1988. 62: 2102-2106.
17. Battegay, M., Moskophidis, D., Rahemtulla, A., Hengartner, H., Mak, T. W. and Zinkernagel, R. M., Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Virol. 1994. 68: 4700-4704.
18. Rahemtulla, A., Fung-Leung, W. P., Schilham, M. W., Kundig, T. M., Sambhara, S. R., Narendran, A., Arabian, A. et al., Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 1991. 353: 180-184.
19. Passlick, B., Flieger, D. and Ziegler-Heitbrock, H. W., Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989. 74: 2527-2534.
20. Ziegler-Heitbrock, L., The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 2007. 81: 584-592.
21. Zhang, J. Y., Zou, Z. S., Huang, A., Zhang, Z., Fu, J. L., Xu, X. S., Chen, L. M. et al., Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS One 2011. 6: e17484.
22. Dolganiuc, A., Oak, S., Kodys, K., Golenbock, D. T., Finberg, R. W., Kurt-Jones, E. and Szabo, G., Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004. 127: 1513-1524.
23. Dolganiuc, A., Chang, S., Kodys, K., Mandrekar, P., Bakis, G., Cormier, M. and Szabo, G., Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 2006. 177: 6758-6768.
24. Ito, T., Wang, Y. H., Duramad, O., Hori, T., Delespesse, G. J., Watanabe, N., Qin, F. X. et al., TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 2005. 202: 1213-1223.
25. Maxwell, J. R., Yadav, R., Rossi, R. J., Ruby, C. E., Weinberg, A. D., Aguila, H. L. and Vella, A. T. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J. Immunol. 2006. 177: 234-245.
26. Boettler, T., Moeckel, F., Cheng, Y., Heeg, M., Salek-Ardakani, S., Crotty, S., Croft, M. et al., OX40 facilitates control of a persistent virus infection. PloS Pathog. 2012. 8: e1002913.
27. Zhang, Z., Zhang, J. Y., Wherry, E. J., Jin, B., Xu, B., Zou, Z. S., Zhang, S. Y. et al., Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 2008. 134: 1938-1949.
28. Zhang, J. Y., Zhang, Z., Wang, X., Fu, J. L., Yao, J., Jiao, Y., Chen, L. et al., PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007. 109: 4671-4678.
29. Zhang, J. Y., Zhang, Z., Jin, B., Zhang, S. Y., Zhou, C. B., Fu, J. L. and Wang, F. S., Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection. J. Immunol. 2008. 181: 3741-3744.
30. Zhang, J. Y., Zhang, Z., Lin, F., Zou, Z. S., Xu, R. N., Jin, L., Fu, J. L. et al., Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010. 51: 81-91.